Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease: Toward the End of a Myth?
Alexandre O. Gérard, Audrey Laurain, Guillaume Favrè, Milou‐Daniel Drici, Vincent Esnault
Topics & Concepts
MedicineKidney diseaseDiabetes mellitusType 2 diabetesDiseaseKidneyInternal medicineEndocrinologyDiabetes Treatment and ManagementPharmacology and Obesity TreatmentPancreatic function and diabetes